These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Scandinavian simvastatin study (4S). Spaulding C; Weber S Lancet; 1994 Dec 24-31; 344(8939-8940):1766; author reply 1767-8. PubMed ID: 7997013 [No Abstract] [Full Text] [Related]
23. Scandinavian simvastatin study (4S). Smith GD; Pekkanen J Lancet; 1994 Dec 24-31; 344(8939-8940):1766; author reply 1767-8. PubMed ID: 7864990 [No Abstract] [Full Text] [Related]
24. Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). Pyörälä K; Ballantyne CM; Gumbiner B; Lee MW; Shah A; Davies MJ; Mitchel YB; Pedersen TR; Kjekshus J; Diabetes Care; 2004 Jul; 27(7):1735-40. PubMed ID: 15220255 [TBL] [Abstract][Full Text] [Related]
25. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Pedersen TR; Kjekshus J; Berg K; Olsson AG; Wilhelmsen L; Wedel H; Pyörälä K; Miettinen T; Haghfelt T; Faergeman O; Thorgeirsson G; Jönsson B; Schwartz JS Circulation; 1996 May; 93(10):1796-802. PubMed ID: 8635258 [TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785 [TBL] [Abstract][Full Text] [Related]
27. The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. Kjekshus J; Pedersen TR; Olsson AG; Faergeman O; Pyörälä K J Card Fail; 1997 Dec; 3(4):249-54. PubMed ID: 9547437 [TBL] [Abstract][Full Text] [Related]
34. Scandinavian simvastatin study (4S). Grodos D; Tonglet R Lancet; 1994 Dec 24-31; 344(8939-8940):1768. PubMed ID: 7997017 [No Abstract] [Full Text] [Related]
35. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Collins R; Armitage J; Parish S; Sleight P; Peto R; Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485 [TBL] [Abstract][Full Text] [Related]
37. Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials). Frey P; Waters DD; DeMicco DA; Breazna A; Samuels L; Pipe A; Wun CC; Benowitz NL Am J Cardiol; 2011 Jan; 107(2):145-50. PubMed ID: 21129718 [TBL] [Abstract][Full Text] [Related]
38. Scandinavian simvastatin study (4S). Manzato E Lancet; 1994 Dec 24-31; 344(8939-8940):1767; author reply 1767-8. PubMed ID: 7997016 [No Abstract] [Full Text] [Related]
39. The 4S study. Implications for prescribing. van Boven AJ; Brügemann J; de Graeff PA; May JF; Crijns HJ Drugs; 1996 Apr; 51(4):507-14. PubMed ID: 8706591 [TBL] [Abstract][Full Text] [Related]
40. The 4S study and its pharmacoeconomic implications. Reckless JP Pharmacoeconomics; 1996 Feb; 9(2):101-5. PubMed ID: 10172696 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]